The high expression of CCN5 in ER-positive advanced BC compared to the low or negative expression of CCN5 in ER-negative advanced BC, suggests an effective regulatory interaction exists between the CCN5 signalling pathway and the ER pathway in BC [36]. The gene discussed is CCN5; the disease is breast cancer.